REGORAFENIB 40

REGORAFENIB 40

Product Details:

  • Supply Ability : 20 Box Per Week
409.70-437.02 USD ($)/Box
X

Price And Quantity

  • 409.70-437.02 USD ($)/Box
  • 2 Box

Trade Information

  • Cash in Advance (CID)
  • 20 Box Per Week
  • 3 Week
  • Sample costs shipping and taxes has to be paid by the buyer
  • 1*28 TAB./BOX
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

In Cancer of colon and rectum

Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Nublexa Tablet treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

SIDE EFFECTS OF NUBLEXA TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Nublexa

  • Infection
  • Low blood platelets
  • Anemia (low number of red blood cells)
  • Rash
  • Weakness
  • Vomiting
  • Pain
  • Nausea
  • Fever
  • Diarrhea
  • High blood pressure
  • Decreased appetite


SHRESTHA GLOBAL PHARMA

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



Back to top
SHRESTHA GLOBAL PHARMA All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.